AD-452

N/A

Report date: 2025/05/13 16:53:18

Base Information

Drug NameAD-452
Drug Alias Name(+) mefloquineAD-452AD 452
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsCytokine synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSosei Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSosei IncTreague Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A